StagMD, a newly formed telehealth company dedicated to men’s health and wellness, announced the launch of its nationwide digital care platform on August 17, 2026. The service is designed to make seeking treatment for sensitive health concerns more private, straightforward, and convenient.
How the Platform Works
Patients begin with a brief online eligibility questionnaire followed by a secure medical intake that is reviewed by an independent U.S.-licensed clinician. Depending on state regulations and individual clinical needs, a phone or video consultation may also be required before any prescription is issued.
Transparent Pricing and Discreet Delivery
StagMD emphasizes clear pricing: the introductory cost is $119 for the first four weeks of treatment and $179 for each subsequent four‑week period, which includes ten single‑dose vials and standard shipping. All medications are compounded by a licensed U.S. pharmacy and shipped in discreet packaging. If a patient is not approved for treatment, the company offers a full refund, and future renewals can be canceled without a cancellation fee, subject to its cancellation policy.
Medication Options
One prescription option the platform may consider is Stag Apex™, a compounded sublingual medication that combines sildenafil, tadalafil, vardenafil, and apomorphine in a single dose. Stag Apex is provided only after an individual medical review and is not FDA‑approved; compounded medications are not reviewed by the FDA for safety, effectiveness, or quality before marketing.
Focus on Privacy and Convenience
According to a company representative, the goal is to reduce embarrassment and logistical barriers that often deter men from seeking care. By moving the initial intake online and offering transparent cost information, StagMD aims to give patients a more convenient way to explore treatment options while maintaining professional medical oversight.
Availability
The platform is now open to eligible patients across the United States. Interested individuals can start the assessment at stagmd.com.
Original reporting: KTBS 3 (Shreveport) — read the source article.
